Statin therapy is the cornerstone of pharmacologic treatment for patients with elevated low-density lipoprotein cholesterol, yet not all patients achieve individualized treatment goals. Primary care physician John Anderson, MD, and cardiologist/lipidologist Seth Martin, MD, discuss common clinical issues in managing patients with complex and challenging dyslipidemia, including elevated lipoprotein (a) (Lp(a)). They highlight key information from recent cholesterol guidelines, including screening and atherosclerotic cardiovascular disease (ASCVD) risk categorization, as well as recommended goals for high-risk primary prevention patients and those with recurrent ASCVD. Drs. Anderson and Martin discuss the roles, benefits, and limitations of pharmacologic treatment options, and strategies to address barriers to nonstatin lipid-lowering therapies. The 0.75-hour activity promotes critical thinking and application of key concepts to patient cases, enabling participants to advance the care they provide to patients with dyslipidemia.
Please visit our related course, Interprofessional Care of Patients with Hyperlipidemia, by clicking here.
Course Credit:
0.75 AMA PRA Category 1 CreditsTM
0.75 ANCC Contact Hours
0.75 CA-BRN Contact Hours
0.50 Pharmacology Hours
Dates:
Opens: 2025-02-28
Closes: 2026-02-28
Target Audience:
This activity is intended for cardiologists, lipidologists, internal medicine specialists, primary care physicians, nurse practitioners, physician associates, and other clinicians managing patients with dyslipidemia.
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
-
John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee -
Seth S. Martin, MD
Director of the Advanced Lipid Disorders Program and Digital Health Lab
Ciccarone Center for the Prevention of Cardiovascular Disease
Professor of Medicine
Johns Hopkins
Baltimore, Maryland
